BUSINESS

• Otsuka to Acquire Transcend for US$700 Million, Snags PTSD Candidate
  March 30, 2026

• Eisai, MSD File Lenvima-Welireg Combo in Japan for RCC
  March 30, 2026

• Chugai CEO Takes Home 441 Million Yen in 2025: Securities Report
  March 30, 2026

• Takeda to Resume MR Vaccine Shipments in June after Potency Issue
  March 30, 2026

• Kyowa Kirin’s Mullick Earns 263 Million Yen in 2025; Workforce Down Sharply
  March 30, 2026

• Amgen Wins Label Update for Imdelltra in Japan following PIII Data
  March 30, 2026

• Eisai, Nuvation Bio’s Taletrectinib Enters EMA Review for ROS1+ NSCLC
  March 30, 2026

• Otsuka Files Iclusig for First-Line Ph+ ALL Use in Japan
  March 30, 2026

• Takeda to Nominate CEO-Elect Kim to Board at June AGM
  March 27, 2026

• Sephience Seen as Potential First-Line PKU Therapy: Professor
  March 27, 2026

• Meiji Pharma, KM Biologics Begin PIII for 6-in-1 Vaccine
  March 27, 2026

• J-TEC Files Dried Allogeneic Cultured Epidermis in Japan
  March 27, 2026

• Pfizer Seeks Methotrexate Label Expansion for GVHD Prevention
  March 27, 2026

• Ono Files Japan NDA For Deciphera-Originated GIST Drug Qinlock
  March 27, 2026

• Forxiga Tops Four Promotion Channels in February: Intage
  March 27, 2026

• J-Pharma Goes Public on TSE, Eyes Licensing of LAT1 Inhibitors
  March 26, 2026

• Asahi Kasei Banks on Tarpeyo to Hit 300 Billion Yen in Pharma Sales by FY2030
  March 26, 2026

• Takeda Unveils Annual 200 Billion Yen Cost Savings by FY2028
  March 26, 2026

• SanBio Targets Akuugo Shipments after May NHI Listing
  March 26, 2026

• Tracleer Generics Add Digital Ulcer Prevention Use
  March 26, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »